Details of the GWAS data in this study. حسب Jing Wang (6206297)

"…The effect of anti-H. pylori IgG seropositivity on CHD may be related to a higher peak insulin response or lower total free cholesterol levels and a decrease in waist circumference and waist-to-hip ratio. …"

Flow Chart of Study Participant Selection. حسب Zhi Jin (3742471)

"…In the fully adjusted model, a significant inverse association was found between sleep duration and CVD risk (OR: 0.92, 95% CI: 0.86–0.99, P = 0.03). …"

Baseline characteristics of participants. حسب Hyungjong Park (10147327)

"…</p><p>Conclusions</p><p>The general population with RHF may have a lower risk of incidence of dyslipidemia. The identified inverse association between RHF and dyslipidemia underscores its significance in risk stratification and preventive interventions in clinical practice.…"

Table 1_Causality of genetically determined serum metabolites on lower back pain or/and sciatica: a comprehensive Mendelian randomized study.docx حسب Yi-Ming Ren (555968)

"…Among them, 8 serum metabolites decreased risk of sciatica or/and lower back pain significantly (P < 0.05), and 14 serum metabolites increased risk of sciatica or/and lower back pain significantly (P < 0.05). …"

Table 5_Causality of genetically determined serum metabolites on lower back pain or/and sciatica: a comprehensive Mendelian randomized study.docx حسب Yi-Ming Ren (555968)

"…Among them, 8 serum metabolites decreased risk of sciatica or/and lower back pain significantly (P < 0.05), and 14 serum metabolites increased risk of sciatica or/and lower back pain significantly (P < 0.05). …"

Table 2_Causality of genetically determined serum metabolites on lower back pain or/and sciatica: a comprehensive Mendelian randomized study.docx حسب Yi-Ming Ren (555968)

"…Among them, 8 serum metabolites decreased risk of sciatica or/and lower back pain significantly (P < 0.05), and 14 serum metabolites increased risk of sciatica or/and lower back pain significantly (P < 0.05). …"

Table 4_Causality of genetically determined serum metabolites on lower back pain or/and sciatica: a comprehensive Mendelian randomized study.docx حسب Yi-Ming Ren (555968)

"…Among them, 8 serum metabolites decreased risk of sciatica or/and lower back pain significantly (P < 0.05), and 14 serum metabolites increased risk of sciatica or/and lower back pain significantly (P < 0.05). …"

Table 3_Causality of genetically determined serum metabolites on lower back pain or/and sciatica: a comprehensive Mendelian randomized study.docx حسب Yi-Ming Ren (555968)

"…Among them, 8 serum metabolites decreased risk of sciatica or/and lower back pain significantly (P < 0.05), and 14 serum metabolites increased risk of sciatica or/and lower back pain significantly (P < 0.05). …"

Data Sheet 5_Causality of genetically determined serum metabolites on lower back pain or/and sciatica: a comprehensive Mendelian randomized study.pdf حسب Yi-Ming Ren (555968)

"…Among them, 8 serum metabolites decreased risk of sciatica or/and lower back pain significantly (P < 0.05), and 14 serum metabolites increased risk of sciatica or/and lower back pain significantly (P < 0.05). …"

Data Sheet 2_Causality of genetically determined serum metabolites on lower back pain or/and sciatica: a comprehensive Mendelian randomized study.xlsx حسب Yi-Ming Ren (555968)

"…Among them, 8 serum metabolites decreased risk of sciatica or/and lower back pain significantly (P < 0.05), and 14 serum metabolites increased risk of sciatica or/and lower back pain significantly (P < 0.05). …"

Data Sheet 6_Causality of genetically determined serum metabolites on lower back pain or/and sciatica: a comprehensive Mendelian randomized study.pdf حسب Yi-Ming Ren (555968)

"…Among them, 8 serum metabolites decreased risk of sciatica or/and lower back pain significantly (P < 0.05), and 14 serum metabolites increased risk of sciatica or/and lower back pain significantly (P < 0.05). …"

Data Sheet 3_Causality of genetically determined serum metabolites on lower back pain or/and sciatica: a comprehensive Mendelian randomized study.xlsx حسب Yi-Ming Ren (555968)

"…Among them, 8 serum metabolites decreased risk of sciatica or/and lower back pain significantly (P < 0.05), and 14 serum metabolites increased risk of sciatica or/and lower back pain significantly (P < 0.05). …"

Data Sheet 1_Causality of genetically determined serum metabolites on lower back pain or/and sciatica: a comprehensive Mendelian randomized study.docx حسب Yi-Ming Ren (555968)

"…Among them, 8 serum metabolites decreased risk of sciatica or/and lower back pain significantly (P < 0.05), and 14 serum metabolites increased risk of sciatica or/and lower back pain significantly (P < 0.05). …"

Data Sheet 4_Causality of genetically determined serum metabolites on lower back pain or/and sciatica: a comprehensive Mendelian randomized study.pdf حسب Yi-Ming Ren (555968)

"…Among them, 8 serum metabolites decreased risk of sciatica or/and lower back pain significantly (P < 0.05), and 14 serum metabolites increased risk of sciatica or/and lower back pain significantly (P < 0.05). …"

Table 1_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.xlsx حسب Erman Wu (19021269)

"…</p>Results<p>In 2021, PMP was responsible for an estimated 651,238 (95% UI, 121,605-1076,503) deaths and 29,098,331(6,988,265-48,127,683) DALY from LRIs globally (ASMR: 8.68; ASDR: 420.09 per 100,000). Despite significant declines since 1990 (ASMR EAPC: -2.44%), profound disparities persisted. …"

Data Sheet 8_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf حسب Erman Wu (19021269)

"…</p>Results<p>In 2021, PMP was responsible for an estimated 651,238 (95% UI, 121,605-1076,503) deaths and 29,098,331(6,988,265-48,127,683) DALY from LRIs globally (ASMR: 8.68; ASDR: 420.09 per 100,000). Despite significant declines since 1990 (ASMR EAPC: -2.44%), profound disparities persisted. …"

Data Sheet 5_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf حسب Erman Wu (19021269)

"…</p>Results<p>In 2021, PMP was responsible for an estimated 651,238 (95% UI, 121,605-1076,503) deaths and 29,098,331(6,988,265-48,127,683) DALY from LRIs globally (ASMR: 8.68; ASDR: 420.09 per 100,000). Despite significant declines since 1990 (ASMR EAPC: -2.44%), profound disparities persisted. …"

Data Sheet 1_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf حسب Erman Wu (19021269)

"…</p>Results<p>In 2021, PMP was responsible for an estimated 651,238 (95% UI, 121,605-1076,503) deaths and 29,098,331(6,988,265-48,127,683) DALY from LRIs globally (ASMR: 8.68; ASDR: 420.09 per 100,000). Despite significant declines since 1990 (ASMR EAPC: -2.44%), profound disparities persisted. …"

Data Sheet 7_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf حسب Erman Wu (19021269)

"…</p>Results<p>In 2021, PMP was responsible for an estimated 651,238 (95% UI, 121,605-1076,503) deaths and 29,098,331(6,988,265-48,127,683) DALY from LRIs globally (ASMR: 8.68; ASDR: 420.09 per 100,000). Despite significant declines since 1990 (ASMR EAPC: -2.44%), profound disparities persisted. …"

Data Sheet 3_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf حسب Erman Wu (19021269)

"…</p>Results<p>In 2021, PMP was responsible for an estimated 651,238 (95% UI, 121,605-1076,503) deaths and 29,098,331(6,988,265-48,127,683) DALY from LRIs globally (ASMR: 8.68; ASDR: 420.09 per 100,000). Despite significant declines since 1990 (ASMR EAPC: -2.44%), profound disparities persisted. …"